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ABSTRACT
Phosphatase and tension homolog (PTEN) is a widely known negative regulator of insulin/
phosphatidylinositol 3-kinase (PI3K) signaling. The PI3K/Akt/mammalian target of rapamycin
(PI3K/Akt/mTOR) and Ras-extracellular signal-regulated kinase (Ras-ERK) signaling pathways are
the chief mechanisms controlling the survival, proliferation, and differentiation of neural stem cells
(NSCs). However, the roles of PTEN in Akt/mTOR and ERK signaling during proliferation and neuronal
differentiation of humanNSCs (hNSCs) are poorly understood. Treatment of proliferating hNSCs with
a specific inhibitor of PTEN or overexpression of the PTEN inactive mutant G129E resulted in an in-
crease in the expression levels of Ki67, p-S6 kinase (p-S6K), and p-ERKwithout affecting p-Akt expres-
sion during proliferation of hNSCs. Therefore, we focused on the regulatory effect of PTEN in S6K and
ERK signaling during dopaminergic neuronal differentiation of hNSCs. Overexpression of PTEN during
neuronal differentiation of hNSCs caused an increase in p-S6K expression and a decrease in p-ERK ex-
pression. Conversely, inhibition of PTEN increased p-ERK expression and decreased p-S6K expression.
Inhibition of ERK by a specific chemical inhibitor, U0126, promoted neuronal generation, especially of
tyrosine hydroxylase-positive neurons. p-S6K expression increased in a time-dependentmanner dur-
ing differentiation, and this effect was enhanced by U0126. These results indicated that PTEN pro-
moted neuronal differentiation by inhibition of ERK signaling, which in turn induced activation of
S6K. Our data suggest that ERKpathways participate in crosstalkwith S6K through PTEN signaling dur-
ing neuronal differentiation of hNSCs. These results represent a novel pathway by which PTEN may
modulate the interplay between ERK and S6K signaling, leading to increased neuronal differentiation
in hNSCs. STEM CELLS TRANSLATIONALMEDICINE 2016;5:1319–1329
SIGNIFICANCE
This article adds to the body of knowledge about the mechanism of extracellular signal-regulated
kinase (ERK)-mediated differentiation by describing the molecular function of phosphatase and
tension homolog (PTEN) during the neuronal differentiation of human neural stem cells (hNSCs).
Previous studies showed that S6K signaling promoted neuronal differentiation in hNSCs via the phos-
phatidylinositol 3-kinase Akt-mammalian target of rapamycin signaling pathway. A further series of
studies investigated whether this S6 kinase-induced differentiation in hNSCs involves regulation of
ERK signaling by PTEN. The current study identified a novel mechanism bywhich PTEN regulates neu-
ronal differentiation in hNSCs, suggesting that activating PTEN function promotes dopaminergic neu-
ronal differentiation and providing an important resource for future studies of PTEN function.
INTRODUCTION
One extrinsic signaling pathway that is a common
mediator of pluripotency in human and mouse
embryonic stem cells (ESCs) is the phosphoinosi-
tide 3-kinase (PI3K)/Akt signaling pathway [1–4].
PI3K/Akt/mammalian target of rapamycin (mTOR)
signaling is a well-defined route by which insulin/
insulin-like growth factor (IGF) receptor stimula-
tion can control neuronal differentiation [5]. In
response to insulin, Akt is phosphorylated at Ser
473 and Thr 308 and translocates to the plasma
membrane. This phosphorylation contributes to
the regulation of differentiation in mouse olfac-
tory bulb stem cells (OBSCs) and rat neural stem
cells (NSCs) [5, 6]. The function of Akt is mediated
through mTOR by activation of p70 ribosomal S6
kinase (S6K).mTOR activity has been linked to cell
growth, proliferation, survival, protein transla-
tion, and other cellular processes [7, 8]. Among
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its many functions, mTOR supports the self-renewal capacity of
human ESCs (hESCs) and NSCs [9, 10]. In contrast, it has been re-
ported to play an important role in differentiation during
embryonic development and in particular the differentiation of
several cell types such as oligodendrocytes and rat NSCs [10–13].
mTOR/S6K has also been shown to regulate differentiation in
hESCs [14].
Another protein involved in thePI3K/Akt pathway is phospha-
tase and tension homolog (PTEN). PTEN is a tumor suppressor
gene that is frequently mutated in human cancer [15]. Although
PTEN is not essential for cell fate determination in the central ner-
vous system (CNS) overall [16, 17], a potential role in differenti-
ation was observed in certain cell types in the brain [5, 18]. Akt
activity is negatively regulated by molecules that antagonize
PI3K, such as the dual lipid and protein phosphatase PTEN [19].
PTENhas been reported to regulate a variety of cellular functions,
such as cell division, survival, apoptosis, migration, and differen-
tiation. Furthermore, there is evidence that PTEN regulates mul-
tiple steps in CNS development [20, 21]. In addition, numerous
studies have established a role for PI3K/Akt/PTEN in stem cells.
In mouse ESCs (mESCs) and adult stem cells, loss of PTEN is cor-
related with the activation of AkT, increased self-renewal, and
proliferation [22–24]. It is well documented that PI3K-dependent
signaling is required formaintenanceof themESCpluripotent state
in mESCs [25].
Extracellular signal-regulated kinase (ERK) is one of the
multiple intracellular effectors downstream of insulin and basic
fibroblast growth factor (bFGF) and is known to crosstalk with
components of other key signaling pathways. ERK plays a crucial
role in the self-renewal of hESCs and hNSCs [4, 26]. However, it
has been reported to play diverse roles in early embryogenesis
and acts in a cell-context-dependent manner. Recently, the ERK
pathway was shown to be involved in the maintenance of self-
renewal properties in association with the PI3K/mTOR pathway
in cancer stem-like cells [27]. However, the role of intracellular
signaling pathways that are activated by extracellular factors in
the regulation of hNSC differentiation and the underlying mech-
anisms remain unknown.
In this study,we investigated the role of PTEN in the control of
hNSC proliferation and differentiation. We further examined the
potential relationship between PI3K/Akt/mTOR and Ras/ERK sig-
naling pathways in hNSCs. We found that inhibition of PTEN de-
creased neuronal differentiation by activation of ERK signaling,
which in turn induced inhibition of S6K. We also showed that
PI3K/Akt/mTOR signaling is essential for hNSC dopaminergic
neuronal differentiation through activation of S6K. In contrast,
ERK promoted hNSC proliferation through inactivation of S6K.
This is the first report of the role of PTEN in crosstalk between
S6K and ERK signaling during neuronal differentiation of hNSCs.
Our findings provide a new insight into a novel regulatory
mechanism of hNSCs and enhance our understanding of the
mechanism of hNSC differentiation during the process of
neurogenesis.
MATERIALS AND METHODS
Reagents and Antibodies
LY294002 and U0126 were purchased from Cell Signaling Technolo-
gies(Danvers,MA,http://www.cellsignal.com);PF-4708671wasfrom
Calbiochem (Darmstadt, Germany, http://www.merckmillipore.com);
and VO-OHpic and rapamycin were from Sigma (St. Louis, MO,
https://www.sigmaaldrich.com). For inhibition of a specific sig-
naling pathway, cells were treated with the appropriate inhibi-
tor during proliferation or differentiation. All reagents were
dissolved in dimethyl sulfoxide (DMSO; Sigma), and controls
were treated with 0.001% DMSO, which was the highest final
concentration of DMSO used in the experiments. Addition of
DMSO did not affect the viability of control samples. Anti-
bodies to the following proteins were obtained from the
indicated commercial sources: p-Akt, p-ERK, p-mTOR, p-S6K,
cleaved caspase-3, and PTEN (Cell Signaling Technologies),
tyrosine hydroxylase (TH) (Pel-Freez, Rogers, AR, http://www.
pelfreez-bio.com), Tuj-1 (Chemicon, Temecula, CA, http://www.
emdmillipore.com), and b-actin (Abcam, Cambridge, U.K.,
http://www.abcam.com).
hNSC Cultures
The hESC culture protocol (HYE-08-03) was approved by the
Hanyang University institutional review board. hNSCs were de-
rived from hESCs (H9, University of Wisconsin, Madison, WI,
http://www.wisc.edu; CHA13, CHA Stem Cell Institute, http://
www.cha.ac.kr) usingan in vitrodifferentiationprotocol involving
neural inductionon feeder layers ofMS5 stromal cells followedby
consecutive cell passages for selection of NSCs, as previously de-
scribed [28]. hNSCs that had undergone 2–8 NSC passages were
used in this study. hNSCs were cultured in serum-free insulin-
transferrin-selenium (ITS) medium [29] in the presence of basic
fibroblast growth factor (bFGF; 20ng/ml; R&DSystems,Minneap-
olis, MN, https://www.rndsystems.com) and ascorbic acid on
poly-L-ornithine/fibronectin-coated culture dishes. Cells were
maintained at 37°C in a 5% CO2 incubator, and the ITS medium
was changed every other day. For differentiation experiments, af-
ter culturing for 1 to 5 days themediumwas changed to differen-
tiation medium (ITS-ascorbic acid [ITS-A] without bFGF).
Characterization of the cultured monolayer of hNSCs is shown
in supplemental online Figure 1.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in phosphate-buffered
saline (PBS), incubated in blocking solution (1% bovine serum
albumin/0.03% Triton X-100 in PBS), and then incubated with the
following primary antibodies: mouse anti-Ki67 (1:100; Novocastra
Laboratories Ltd., Newcastle, U.K., http://www.novocastra.co.uk),
rabbit anti-Nestin (1:50; Dr. Ron McKay, National Institutes of
Health, Bethesda, MD), mouse anti-GFP (1:1,000; Roche Life Sci-
ence, https://lifescience.roche.com), mouse anti-Tuj1 (1:2000;
Babco, Richmond, CA, http://www.babco.com), and rabbit anti-
TH (1:1000; Pelfreez). The following secondary antibodies were
used for visualization: Alexa 488 (1:200; Thermo Fisher Scientific,
Waltham, MA, http://www.thermofisher.com) and Cy3 (1:200;
Jackson Immunoresearch Laboratories, West Grove, PA, https://
www.jacksonimmuno.com/). The stained samples were mounted
inVectashieldwith 49,6-diamidino-2-phenylindole (DAPI)mounting
medium (Vector Laboratories, Burlingame, CA, https://www.
vectorlabs.com)andphotographedusing anepifluorescencemicro-
scope (Leica, Wetzlar, Germany, http://www.leica-microsystems.
com). Immunoreactive/DAPI-stained cells on culture coverslips
were counted in at least 20 randomly selectedmicroscopic fields us-
ing an eyepiece grid at a final magnification of3200 or3400.
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Western Blot Analysis
To determine levels of protein expression, we prepared protein ex-
tracts fromhNSCs forWesternblotting.Adherentcellswerescraped
off the culture dishes and lysed by incubation on ice with radio-
immunoprecipitation assay lysis buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 1% sodium deoxycholate, 1% NP-40, 0.1% sodium
dodecyl sulfate [SDS]) containing 1mMphenylmethylsulfonyl fluo-
ride, protease inhibitor cocktail, and phosphatase inhibitor cocktail
(Roche, Indianapolis, IN, https://www.roche.com). Collected cells
were broken by sonication on ice and centrifuged at 10,000g for
20 min at 4°C. Protein concentrations were determined with the
Bradford reagent, and 30-mg samples of extracted protein were
resolved on SDS-polyacrylamide gels and transferred to nitrocel-
lulose membranes. The membranes were incubated in the pres-
ence of different primary antibodies at 4°C overnight and then
incubated with secondary antibody coupled to horseradish per-
oxidase. Immunoreactivity was visualized using enhanced chemi-
luminescence (GE Healthcare Life Sciences, Little Chalfont, U.K.,
http://www.gelifesciences.com). Protein bands were quantified
with a densitometer (VERSAmax; Molecular Devices, Sunnyvale,
CA, https://www.moleculardevices.com).
Transduction of hNSCs With Retroviral Vectors
The retroviral vector pCL [30] was modified to give the con-
struct pC5w2-IRES3-green fluorescent proteins (GFP), simulta-
neously expressing the GFPs. Infection was performed using a
Moloney murine leukemia virus (Mo-MLV)-based retroviral
vector. This GFP vector was used as a control in transduction
experiments. A construct containing the complete PTEN cDNA
(1.2 kb) fused to the hemagglutinin (HA)N-terminuswas cloned
into the pC5w-IRES-GFP vector to generate the vector pC5w-
HA-PTEN-IRES-GFP (PTEN-GFP) in which PTEN expression was
under control of the viral long terminal repeat (LTR). The PTEN
catalytically inactive mutant (PTEN-G129E) that was recently
described and characterized was also cloned into the pC5w-
IRES-GFP vector. In addition, constructs containing constitu-
tively active S6K1 (S6K1-CA) and S6K1 dominant negative
(S6K1-DN) cDNAs fused to themyc N-terminus were subcloned
into the pC5w2-IRES3-GFP vector to generate the plasmids,
pC5w2-myc-S6K1-CA-IRES3-GFP (S6K1-CA-GFP) and pC5w2-
myc-S6K1-DN-IRES3-GFP (S6K1-DN-GFP), in which expression
of S6K1-CA and S6K1-DN, respectively, is under the control
of theMo-MLV LTR. The S6K1-CA and S6K1-DN constructs were
Figure 1. Phosphatidylinositol 3-kinase/Akt/mTOR is involved in the induction of dopaminergic neuronal differentiation of humanneural stem
cells (hNSCs). Differentiation of H9-hNSCs was induced by culturing the cells for 5 days in the absence of basic fibroblast growth factor (bFGF).
hNSCs were exposed to insulin (0 to 1 mM) in the presence or absence of rapamycin. (A): Immunofluorescence analyses were performed for
TuJ-1 (red) and TH (green); blue: DAPI (magnification3200). Cells positive for THwere quantified as the percentage of total cells. (B):Whole-cell
proteins (30 mg) were analyzed for TH and b-actin expression by Western blotting. Each blot represents three independent experiments. (C):
Differentiation of hNSCs was induced by culturing for 5 days in the absence of bFGF, and the intracellular signaling cascade during insulin-in-
duced dopaminergic neuronal differentiation was examined. Whole-cell proteins (30mg) were analyzed for p-Akt, p-mTOR, p-S6K, and b-actin
expression byWestern blotting. Error bars are standard errors of themean (SE). p,p, .05, in comparisonwithwithdrawal rapamycin cells. Scale
bar =20mm.Abbreviations: DAPI, 49,6-diamidino-2-phenylindole;mTOR,mammalian target of rapamycin; p, phosphorylated; Rapa, rapamycin;
S6K, S6 kinase; TH, tyrosine hydroxylase.
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kindly provided by Dr. Sunghee Um of Sungkyunkwan Univer-
sity (Suwon, Republic of Korea).
The retroviral vectors were transfected into 293 GPG packaging
cells (Lipofectamine2000;ThermoFisherScientific)andsupernatant
containing viral particles (vesicular stomatitis virus glycoprotein G
pseudotyped recombinant retrovirus) was harvested 72 hours after
incubation. Viral titers were adjusted to 13 108 particles per milli-
liter. Neural precursors were exposed to viral supernatant for 4
hours in the presence of polybrene (1 g/ml), cultured overnight in
ITS-Amedium plus bFGF, and induced to differentiate the following
day by withdrawal of bFGF.
Statistical Analysis
Statistical comparisons were performed with SPSS software (version
17.00, SPSS Inc., Chicago, IL, http://www.ibm.com). One-way analysis
ofvariancefollowedbyBonferroni’stestwasappliedformultiplecom-
parisons. Data are expressed as mean6 SEM of at least three inde-
pendent experiments.We considered p, .05 statistically significant.
RESULTS
Characterization of hNSCs Derived From hESCs
hNSCs derived from H9 ESCs were grown in the presence of bFGF
and then differentiated toward predominantly neuronal popula-
tions of the central nervous system followingwithdrawal ofmito-
gens. The cells formed neural rosette structures and abundantly
expressed hNSC-specific markers such as nestin or Sox2 and the
proliferating cell marker Ki67 (supplemental online Fig. 1A–1C).
After 5 days of differentiation, we determined expression of
the neuronal marker, TuJ1, and the dopaminergic neuronal
marker, TH, by immunostaining (supplemental online Fig. 1D).
Insulin Activates S6K ThroughPI3K/Akt/mTORSignaling
Pathways in hNSCs
To investigate the insulin effect on PI3K/AKT/mTOR signaling
pathways in hESC-derived NSCs, we detected the phosphoryla-
tion levels of AKT, Mtor, and S6K 1 day after insulin treatment
by Western blotting. Insulin increased the expression levels of
p-AKT, p-mTOR, and p-S6K in H9 ESC-derived hNSCs in a
concentration-dependent manner (supplemental online Fig.
2A). In addition, we examined the effect of insulin in hNSCs de-
rived from other ESC lines such as CHA13 ESCs and obtained
the same results as described above (supplemental online Fig.
2B). The Akt/mTOR/S6K signaling effects of insulin were blocked
by the PI3K inhibitor, LY294002 (supplemental online Fig. 2A, 2B).
Thesedata show that insulin activatedmTOR/S6Kvia thePI3K-Akt
signaling pathway in our culture system.
Induction of Dopaminergic Neuronal Differentiation by
Insulin Is Dependent on the mTOR Signaling Pathway
Next, we examined whether the dose-dependent insulin effect
was involved in the induction of dopaminergic neurons. Differen-
tiationofhNSCswas inducedby culturing for5days in theabsence
of bFGF. hNSCs were exposed to insulin (0 to 1 mM) in the pres-
ence or absence of rapamycin. At concentrations from 0 to 1mM,
insulin induced a dose-dependent increase in the number of
dopaminergic neurons. As shown in Figure 1A, there was an in-
crease in the percentage of cells positive for the neuronal marker
TuJ1 and the percentage of cells positive for the dopaminergic
neuronal marker TH. However, relative induction of TuJ1-
positive and TH-positive neurons to TuJ1-positive neurons was
decreased when rapamycin was added to the medium (Fig. 1A).
In the absence of rapamycin, the expression of TH was
Figure 2. Extracellular signal-regulated kinase inhibition attenuated
proliferation of human neural stem cells (hNSCs). (A): Cells were cul-
tured for 3 days under conditions of proliferation in the presence or
absence of U0126 (5 or 10mM). Representative immunofluorescence
for Ki67 (red) and fluorescence of DAPI (blue) is shown. Treatment
with U-0126 attenuated Ki67-positive cells in a dose-dependent
manner. (B): Representative immunofluorescence for Ki67 (red)
and fluorescence of DAPI (blue) is shown. Treatment with 10 mM
U-0126-attenuated Ki67-positive cells in a time-dependent man-
ner. (C):hNSCswere treatedwithU0126 for 3 days, and lysateswere
subjected to immunoblotting for PCNA and b-actin, as indicated.
Each blot represents three independent experiments. Scale bar =
20mm. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; PCNA,
proliferating cell nuclear antigen.
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significantly increased in an insulin dose-dependent manner in
comparisonwith cells in insulin-freemedium, asmeasured by im-
munoblot analysis. However, rapamycin reduced TH expression
even in the absence of insulin (Fig. 1A, 1B). Importantly, levels
of Akt, mTOR, and S6K increased during differentiation of hNSCs
for 5 days (Fig. 1C). These results showed that the PI3K-Akt path-
way is an important mediator of the intracellular signal cascade
during insulin-induced neuronal differentiation of hNSCs. Fur-
thermore,mTORplays apositive role in the insulin-induceddiffer-
entiation of hNSCs into dopaminergic neurons.
Effects of ERK Signaling Pathway in the Proliferation and
Differentiation of hNSCs
Wenext investigatedwhether inhibitionof ERKbyU0126affected
the proliferation and differentiation of hNSCs. After exposure of
hNSCs to inhibitor for 3 days, the number of Ki67-positive cells
decreased in a dose-dependent manner (Fig. 2A) and time-
dependent manner (Fig. 2B), and the expression of proliferating
cell nuclear antigen (PCNA) also decreased (Fig. 2C). bFGF has
been shown to promote the proliferation of NSCs thorough acti-
vation of ERK, whereas withdrawal of bFGF induces differentia-
tion. During differentiation of hNSCs induced by the removal of
bFGF, the expression of ERK was decreased in comparison with
that in proliferating hNSCs (Fig. 3A). These results showed that
ERK plays an important role in the maintenance of prolifer-
ation in these cells. Interestingly, S6K was activated by inhibition
of ERK. U0126 treatment abolished the expression of p-ERK
(Fig. 3B). Relative induction of TuJ1- and TH-positive neurons to
TuJ1-positive neurons was increased when ERK signaling was
blocked in differentiating cells (Fig. 3C). Western blot analysis
showed that treatment with U0126 increased the expression of
TH and TuJ1 in cells derived fromH9 ESCs in comparisonwith con-
trols (Fig. 3D). To clarify the reverse effect of S6K inhibition on do-
paminergic neuronal differentiation of hNSCs, we examined the
effect of S6K inhibition on ERK inhibition during dopaminergic
neuronal differentiation of hNSCs. As was expected, chemical in-
hibition of S6K in differentiating cells using PF4708671 blocked
the increase of TH expression induced by ERK inhibition (Fig. 3E).
Promotion of Cell Proliferation by PTEN Inhibition
During Proliferation of hNSCs
To further study the influence of the PI3K-Akt pathway on the
proliferation of hNSCs, we treated cells with retroviral vector
Figure 3. Extracellular signal-regulated kinase (ERK) inhibition pro-
moted dopaminergic neuronal differentiation of human neural stem
cells (hNSCs). (A): hNSCs were treated with or without U0126 during
proliferation (with bFGF) and differentiation (in the absence of bFGF).
Cell lysates were subjected to immunoblotting with p-ERK and
b-actin, as indicated. Each image is representativeof threedifferent ex-
periments. (B): Differentiating hNSCs were treated with U0126 for 5
days,andlysatesweresubjectedto immunoblottingforp-ERK,p-mTOR,
p-S6K, and b-actin, as indicated. Each blot represents three indepen-
dent experiments. (C):Differentiating cellswithorwithoutU0126 treat-
ment at day 5 were subjected to immunofluorescent staining with
anti-TuJ-1 (red) and anti-TH (green); blue: DAPI. Cells positive for TH
were quantified as the percentage of total cells. (D):Western blot anal-
ysis of TuJ-1, TH, and b-actin in hNPCs after treatment with 10 mM
U0126 during differentiation at 1, 3, and 5 days in H9 embryonic stem
cell-derivedhNSCs. Thedensitiesofproteinbandswerequantifiedusing
scanningdensitometry, and the ratioof TuJ1orTH tob-actin is shown in
each panel. (E): Differentiating cells treated with 10 mMU0126 only or
cotreatmentwith 10mMPF-4708671 at day 5were subjected to immu-
nofluorescence with anti-TuJ-1 (red) and anti-TH (green) antibodies;
blue indicates DAPI staining. Error bars are standard errors of themean
(SE). p, p, .05; pp, p, .001; in comparisonwithwithdrawal rapamycin
cells. Scale bar = 20 mm. Abbreviations: bFGF, basic fibroblast growth
factor; DAPI, 49,6-diamidino-2-phenylindole; ERK, extracellular signal-
regulated kinase;mTOR,mammalian target of rapamycin; p, phosphor-
ylated; S6K, S6 kinase; TH, tyrosine hydroxylase.
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expressing GFP only (GFP), PTEN-GFP (PTEN), or a catalytically inac-
tive PTEN mutant (PTN-G129E-GFP [PTEN GE]). Similar infection ef-
ficiencies were obtained when cells were infected with the GFP,
PTEN, and PTEN GE vectors, as confirmed by immunoblotting with
antibody againstGFP (Fig. 4A). The total number of Ki67-labeled cells
was similar in the PTEN-infected cells and the GFP-infected cells. In
contrast, overexpression of mutant PTEN GE caused an increase in
the number of Ki67-positive neurons (Fig. 4B).We performed an im-
munoblotting assay to determine whether overexpression of PTEN
or PTEN GE affects Akt and ERK phosphorylation and found that
p-Akt levels were reduced in cells infected with the PTEN construct,
whereas overexpression of PTEN did not affect p-ERK levels during
proliferation (Fig. 4C). PTENGEoverexpression inproliferatinghNSCs
was not increased p-Akt levels, and levels of both p-ERK and p-S6K
were significantly increased in proliferating hNSCs (Fig. 4C).
Because PTEN is known to be a negative regulator of Akt, we
confirmed the effects of PTEN on differentiating hNSCs using VO-
OHpic, a specific inhibitor of PTEN. We also evaluated the effects
of PTEN inhibition on proliferating hNSCs by immunolabeling of
proliferative cells with anti-Ki67 (Fig. 4E). VO-OHpic is an ex-
tremely potent inhibitor of PTEN with nanomolar affinity in vitro
and in vivo. Treatment of hNSCs with 200 and 400 nM VO-OHPic
reduced the level of PTEN and increased the level of p-PTEN, an
inhibitory phosphorylated formof PTEN (Fig. 4D). Furthermore, in
comparisonwith untreated cells, VO-OHpic increased the expres-
sion of p-Akt and p-ERK, accompanied by an increase in the num-
ber of Ki67-positive cells (Fig. 4D, 4E).
PTEN Promotes Dopaminergic Neuronal Differentiation
of hNSCs
We next examined the regulatory effect of PTEN on S6K and
ERK signaling during dopaminergic neuronal differentiation
of hNSCs. Overexpression of PTEN resulted in an increase in
the expression level of p-S6K and a decrease in p-Akt and
p-ERK expression. Conversely, overexpression of the inactive
mutant G129E decreased p-S6K expression and increased ex-
pression levels of p-Akt and p-ERK (Fig. 5A). PTEN overexpres-
sion in hNSCs that were induced to differentiate in the absence of
bFGF caused an increase in the level of THexpression and thenum-
ber of TH-positive cells; however, overexpression of PTEN G129E
resulted in a decrease in TH expression and TH-positive cells (Fig.
5B, 5C). As was expected, chemical inhibition of PTEN in differenti-
ating cells using VO-OHpic caused a reduction in the number of TH-
and TuJ1-positive cells, accompanied by activation of Akt and ERK
(Fig. 5D, 5E), and blocked TH expression (Fig. 5D, 5F). In addition,
chemical inhibition of ERK in differentiating cells using U0126
blocked the decrease of TH expression induced by PTEN inhibition
(Fig. 5D). Contrary to our speculation, these results showed that
PTEN inhibition resulted in decreased differentiation, even though
the level of p-Akt was increased.
Figure 4. PTEN inhibition promoted the proliferation of human neu-
ral stem cells (hNSCs). (A): hNSC cultures were infected in parallel
with vectors expressing PTEN-GFP, PTEN G129E-GFP, or GFP and cell
lysateswere subjected to immunoblottingwith antibody againstGFP.
(B): Infected cells were cultured for 3 days in conditions of prolifera-
tion. Representative immunofluorescence for Ki67 (red) and fluores-
cent staining of DAPI (blue), and the proportion of Ki67-positive cells
were calculated. (C): Lysates of proliferative cells were subjected to
immunoblotting for PTEN, p-Akt, p-S6K, p-ERK, and b-actin, as indi-
cated. Each blot represents three independent experiments. Chem-
ical inhibition of PTEN increases proliferation of hNSCs. hNSCs were
treated with or without VO-OHpic during proliferation (in the presence
of basic fibroblast growth factor) (D, E). (D): hNSCs were cultured under
conditions of proliferation in the presence or absence of VO-OHpic
(200 or 400 nM) for 5 days, and lysates were subjected to immunoblot-
tingwith PTEN, p-PTEN, p-Akt, p-ERK, andb-actin, as indicated. Each blot
represents three independent experiments. (E):Representative immu-
nofluorescence for Ki67 (red) and fluorescent staining of DAPI (blue)
are shown, and the proportion of Ki67-positive cells was calculated.
Error bars are standard errors of themean (SE). pp, p, .001 in com-
parison with control cells. Scale bar = 20 mm. Abbreviations: DAPI,
49,6-diamidino-2-phenylindole; ERK, extracellular signal-regulated
kinase; GE, PTN-G129E-GFP (a catalytically inactive PTEN mutant);
GFP, green fluorescent protein; p, phosphorylated; PTEN, phospha-
tase and tension homolog; PTEN GE, a catalytically inactive PTEN
mutant; S6K, S6 kinase.
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Inhibition of ERK Signaling Promoted Dopaminergic
Neuronal Differentiation Through S6K Signaling
Finally, we examined whether modulation of S6K signaling was
directly involved in dopaminergic neuronal differentiation of
hNSCs. We observed that S6K signaling is an ultimate signal of
the insulin signaling cascade during dopaminergic neuronal dif-
ferentiation of hNSCs (supplemental online Fig. 2). In addition,
the expression of S6K increased in a time-dependent manner
during hNSC differentiation (Fig. 6A). Moreover, the level of
p-S6K was increased by U0126 treatment (Fig. 6A). The activity
of S6K was associated with differentiation of hNSCs. As was
expected, inhibition of S6K significantly reduced TH expression
(Fig. 6B).
To further study the influence of the S6K signaling pathway
on dopaminergic neuronal differentiation of hNSCs, we treat-
ed cells with a retroviral vector expressing constitutively active
S6K1 (S6K1-CA-GFP) or dominant negative mutant S6K1 (S6K1-
DN-GFP). Similar transduction efficiencies between the two
constructs were confirmed by immunoblot analysis of lysates
of the transduced cells using an antibody against GFP (Fig. 6C).
S6K1-CA overexpression in hNSCs that were induced to differ-
entiate in the absence of bFGF caused an increase in the num-
ber of TH-positive cells; however, S6K1-DN overexpression
resulted in a decrease in TH-positive cell numbers (Fig. 6C).
These results show that S6K1 promotes dopaminergic neuro-
nal differentiation of hNSCs. Our findings indicate the require-
ment for S6K in hNSC differentiation and suggest that S6K is
regulated by ERK signaling pathways.
DISCUSSION
Here, we describe a novel interaction by which the ERK and S6K
cascades are modulated by PTEN during proliferation and dopa-
minergic neuronal differentiation of hNSCs. We found that (a)
Akt/mTOR signaling is essential for coordinating dopaminergic
neuronal differentiation; (b) mTOR signaling and its down-
stream effector S6K play a key role in this differentiation; (c)
ERK signaling maintains the proliferative capability of hNSCs;
(d) PTEN regulates proliferation and differentiation through
modulation of the expression level of ERK; (e) inhibition of
ERK signaling promotes the dopaminergic neuronal differentia-
tion of hNSCs via activation of S6K; and (f) PTEN regulates the
S6K crosstalk of ERK signaling during dopaminergic neuronal
differentiation.
Importantly, dopaminergic neuronal differentiation depended
on the concentration of insulin in our culture system. In addition,
the levels of p-Akt, p-mTOR, and p-S6K—phosphorylated proteins
Figure 5. PTEN promoted dopaminergic neuronal differentiation of
human neural stem cells (hNSCs). hNSC cultures were infected in par-
allel with vectors expressing PTEN-GFP, PTEN G129E-GFP, and GFP.
After 3 days, the infected cells were cultured for a further 5 days in
conditions of differentiation. (A): Lysates from differentiating cells
were subjected to immunoblot analysis of PTEN, p-Akt, p-S6K, p-ERK,
and b-actin, as indicated. (B, C): Differentiating cells were subjected
to immunoblotting (B) and immunofluorescent staining (C) with anti-
TH antibody (red). Green: GFP; blue: DAPI (n = 5). (D–F): Chemical
inhibition of PTEN decreases dopaminergic neuronal differentiation.
hNSCswere treatedwith orwithout VO-OHpic during differentiation
(in the absence of basic fibroblast growth factor). Cells positive for
TH were quantified as the percentage of GFP-positive cells. (D):
Differentiating cells treated with VO-OHpic only or cotreatment
with 10 mM U0126 at day 5 were subjected to immunofluores-
cence with anti-TuJ-1 (red) and anti-TH (green) antibodies; blue
indicates DAPI staining. (E): Western blot analysis of PTEN, p-PTEN,
p-Akt, p-ERK, p-S6K, and b-actin in hNPCs after treatment with 200
or400nMVO-OHpicduringdifferentiationfor5days.EachWesternblot
image is representativeof threedifferentexperiments. (F):Differentiat-
ing cells with orwithout VO-OHpic treatment for 5 dayswere subjected
to immunoblotting for TH andb-actin, as indicated. Error bars are stan-
darderrorsof themean (SE).p,p, .05, in comparisonwithcontrol cells.
Scale bar = 20mm.Abbreviations:DAPI, 49,6-diamidino-2-phenylindole;
ERK, extracellular signal-regulated kinase; GFP, green fluorescent pro-
tein; p, phosphorylated; PTEN, phosphatase and tensionhomologPTEN
GE, a catalytically inactive PTEN mutant; S6K, S6 kinase; TH, tyrosine
hydroxylase.
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involved in the insulin-mediated signal cascade—were increased
during differentiation of hNSCs into dopaminergic neurons. Our
previous reports showed the positive function of insulin in the do-
paminergic neuronal differentiation of hNSCs [31]. mTOR is a well-
knowndownstreameffector ofPI3K/Akt. AlthoughmTORhasbeen
reported toregulate cell growth, inourpreviousstudy, inhibitionof
mTOR by rapamycin did not affect proliferation, and proliferating
hNSCs maintained the capacity for self-renewal even under condi-
tions of mTOR inhibition. In the present study, the expression of
p-mTOR was increased during dopaminergic neuronal differentia-
tion.We found that rapamycin treatment decreaseddopaminergic
neuronal differentiationeven in the absenceof insulin. Thismaybe
related to previous observations that neuronal differentiation
maintained by endogenous insulin is blocked by rapamycin [6].
Our results showed that inhibition of mTOR abrogated the phos-
phorylation of mTOR and significantly decreased the number of
TuJ1- and TH-positive neurons and the expression level of these
proteins. In addition, the number of functional dopaminergic neu-
rons also decreased after rapamycin treatment. pS6K is a well-
characterized downstream effector of mTOR. Activation of S6K is
proposed to be a physiological regulator in the transition fromplu-
ripotent hESCs to differentiated cells [32]. We previously reported
that S6K is necessary for the differentiation of hNSCs and that S6K
activation promotes dopaminergic neuronal differentiation of
hNSCs [31].
Because PTEN negatively regulates the PI3K/Akt pathway, we
performed experiments to study the influence of the PI3K-Akt
pathway on dopaminergic neuronal differentiation using hNSCs
that were retrovirally infected with wild-type PTEN or an inactive
PTEN mutant. The PTEN tumor suppressor gene was the first
phosphatase gene shown to frequently exhibit somatic mutation
in various human cancers, including glioma. PTEN and PI3K have
opposing effects on phosphatidylinositol phosphate levels and,
consequently, opposing effects on cell proliferation and survival
[33, 34]. Besides carcinogenesis, PTENmay play a critical role in
neurogenesis, as suggested by the increased proliferation ob-
served in mice andmouse NSCs lacking PTEN [16]. We found that
the proliferation of hNSCs was similar in the PTEN-infected cells
and the GFP-infected cells. In contrast, overexpression of mutant
PTEN GE caused an increase in the number of Ki67-positive neu-
rons.Underour experimental condition, themoderate increase in
the levels of PTEN did not affect the proliferation of hNSCs in the
presence of bFGF. These mitogens activate the ERK1/2 pathways
[35] and could then counteract the putative effects of PTEN phos-
phatase activity on proliferation. A previous study reported that
PTEN overexpression did not affect the proliferation of OBSCs in
the present bFGF and EGF [5]. Accordingly, we cannot rule out
a role for PTEN in maintaining the homeostasis of the cell prolif-
eration in hNSCs. PTEN expression is induced during neuronal
differentiation, and suppression of PTEN levels decreases the
yield of neuronal cells [36, 37]. In addition, loss of PTEN leads
to the exhaustion of adult hematopoietic stem cells [38, 39], and
conditional deletion of PTEN in both embryonic and adult NSCs
promotes sustained self-renewal and stem/progenitor expansion
[16, 24]. Similarly, we observed that inhibition of PTEN by a PTEN
inactivemutant or specific chemical inhibitor blocked the appear-
ance of TH-positive neurons accompanied by enhancement of
proliferation. In contrast to our results, a previous study showed
that loss of PTEN promoted differentiation of mouse OBSCs into
neurons and astrocytes and that PTEN overexpression decreased
the differentiation of these cells only in the absence of insulin/
Figure 6. Suppression of S6K decreases cell number anddopaminer-
gic neuronal differentiation. (A): Differentiating human neural stem
cells (hNSCs) were treated with U0126 for 5 days, and lysates were
subjected to immunoblotting forp-S6Kandb-actin, as indicated. Each
blot represents three independent experiments. (B): Western blot
analysis of TH and b-actin in hNPCs after treatment with 10 mM
PF-4708671 during differentiation at 1, 3, and 5 days in H9 embryonic
stem cell (ESC)-derived hNSCs. (C): hNSCs were treated with a retro-
viral vector expressing constitutively active S6K1 (S6K1-CA-GFP) or
dominant negativemutant S6K1 (S6K1-DN-GFP). Similar transduction
efficiencies between the two constructs were confirmed by immuno-
blot analysis of lysates of the transduced cells using an antibody
against GFP. Overexpression of S6K1-CA in hNSCs that were induced
to differentiate in the absence of basic fibroblast growth factor
caused an increase in the number of TH-positive cells; however,
overexpression of S6K1-DN resulted in a decrease in the number
of TH-positive cells. Scale bar = 20 mm. Abbreviations: CA, constitu-
tively active; DAPI, 49,6-diamidino-2-phenylindole; DN, dominant
negative; GFP, green fluorescent proteins; p, phosphorylated; S6K,
S6 kinase; TH, tyrosine hydroxylase.
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IGF-1 [5]. In addition, PTEN knockout mice do not show any
changes in the number of neurons or astrocytes [16]. Inhibition
of PTEN leads to death of the resulting immature neurons, but
PTEN is not required for astrocytic differentiation [36]. The nu-
clear localization of PTEN in PC12 cells is associated with cell-
cycle arrest in G1 [36]. These discordant results probably reflect
differences in the influence of PTEN depending on cell type, its
subcellular localization, developmental stage, and extracellular
components such as insulin. In this study, inhibition of PTEN by
treatment with a specific inhibitor stimulated levels of both
p-Akt and p-ERK in hNSCs. However, we could not observe
the increase of p-AKT level by overexpression of PTEN GE mu-
tant. These observations were not expected, and we did not
know why this happened. However, we consistently obtained
the increase of p-S6K and p-ERK upon the overexpression of
PTEN GE. In contrast, the number of TH-positive neurons was
increased in hNSCs overexpressing PTEN in comparison with
those that overexpressed the PTEN inactive mutant or were
treated with specific PTEN inhibitor. Moreover, the expression
of ERK was not increased in hNSCs overexpressing PTEN. PTEN
overexpression in PC12 cells inhibits neuronal differentiation
with a reduction in both p-Akt and p-ERK [40]. Although
p-Akt expression was increased by inhibition of PTEN in our ex-
perimental conditions, the differentiation of hNSCs was de-
creased. We expected to observe an increase in p-Akt levels
in hNSCs that inhibits the PTEN signaling concomitant with
the increase in hNSC differentiation; however, we obtained
the opposite result. The major finding of the present study is
that the effects of PTEN on S6K phosphorylation lead to dopa-
minergic neuronal differentiation via the ERK signaling path-
way. We found that the expression of ERK was increased in
cells expressing a PTEN inactivemutant and in cells treatedwith
a PTEN-specific inhibitor in both the presence and absence of
bFGF. Interestingly, the increase in p-ERK was accompanied
by a reduction in p-S6K, despite the induction of Akt by PTEN
inhibition. These results show that PTEN modulates both pro-
liferation and differentiation through the regulation of ERK.
We therefore examined the role of ERK during the proliferation
and differentiation of hNSCs.
Fibroblast growth factors are major factors involved in the
self-renewal of hESCs and have been shown to activate the ERK
cascade [26, 41]. ERK is known to have cell survival effects; how-
ever, in neurons, ERK has been reported to be involved in both
positive and negative regulation of differentiation, depending
on extracellular stimuli [42–44]. Of interest, a recent finding sug-
gests cross-inhibitory regulation between the PI3K/Akt and Ras/
ERK signaling pathways, by which each contributes to the self-
renewal and differentiation of glioma stem-like cells [27]. There-
fore, increased ERK activity might be masking the effect of p-Akt
on the activation of mTOR or S6K. In this study, we identified a
role of the ERK pathway during proliferation and dopaminergic
neuronal differentiation of hNSCs. Inhibition of ERK reduced the
number of proliferating NSCs and enhanced the expression of
TuJ1- and TH-positive neurons and their immunoreactivity in dif-
ferentiating neurons. We also found that the expression of ERK
was reduced during differentiation. Importantly, inhibiting ERK
significantly increased the levels of p-S6K without activation of
Akt and mTOR. These results indicated that ERK might directly
inhibit S6K. This phenomenon was confirmed by Western blot
analysis of hNSCs with or without U0126 and rapamycin treat-
ment during differentiation. We showed that levels of S6K
gradually increased during differentiation from days 1 to 5
and that the expression of S6K was higher in U0126-treated
cells. Furthermore, the mTOR inhibitor rapamycin completely
abolished S6K signaling. Treatment with rapamycin did not im-
pair proliferation, althoughweobserved decreased dopaminer-
gic neuronal differentiation. Activation of S6K is proposed to be
a physiological regulator in the cascade from pluripotent hESCs
to differentiation [32]. Many developmental models have
shown that the onset of protein synthesis is vital for generating
and maintaining a differentiated state. S6K acts on many sub-
strates in addition to ribosomal protein S6, including transcrip-
tion factors, RNA helicases, and other protein substrates
involved in translation initiation and elongation [45]. To deter-
mine whether S6K is dispensable for the maintenance of prolif-
eration of hNSCs, we selectively inhibited S6K using a specific
inhibitor and found that inhibition of S6K inhibits dopaminergic
neuronal differentiation without affecting hNSC proliferation.
These results imply that constant regulation of mTOR/S6K sig-
naling is required for dopaminergic neuronal differentiation. Fi-
nally, ERK signaling is one of the effectors downstream of PTEN
signaling. As shown in this study, PTEN blocks ERK signaling and
Figure7. Diagramshowing the regulationof dopaminergic neuronal
differentiation of human neural stem cells (hNSCs). ERK signaling is
one of the effectors downstream of PTEN signaling. We showed
that PTEN blocks ERK signaling and that ERK promotes dopaminer-
gic neuronal differentiation through S6K signaling pathway in
hNSCs. Abbreviations: DA, dopaminergic; ERK, extracellular signal-
regulated kinase; FGF, fibroblast growth factor; mTOR, mammalian
target of rapamycin; p, phosphorylated; PTEN, phosphatase and ten-
sion homolog; S6K, S6 kinase.
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ERK promotes neuronal generation, especially dopaminergic
neuronal differentiation through the S6K signaling pathway in
hNSCs (Fig. 7).
This study identified a novel regulatory system operating in
hNSCs andprovidednewevidence for themechanismsbywhich
PI3K/Akt/mTOR and ERK are linked to the regulation of S6K.
PI3K/Akt signaling is required for cell survival and differentia-
tion of hNSCs. During differentiation of hNSCs into dopaminer-
gic neurons, the insulin-mediated signal cascade involving
p-Akt, p-mTOR, and p-S6K is activated. We also found that
mTOR/S6K plays a key role in the differentiation of hNSCs. Sig-
nificantly, PTEN regulates S6K via ERK signaling. Because ERKhas
an inhibitory effect on S6K, this may help to maintain the pro-
liferative state of hNSCs. This is the first report of the link be-
tween PI3K/Akt/mTOR and ERK and the regulation of S6K
through PTEN in hNSCs. Discovery of the key mechanisms in-
volved in maintaining proliferation and differentiation of hNSCs
is necessary before cell therapy can achieve a high degree of ef-
ficiency. Our findings might help to improve stem cell therapy
quality control and minimize the risks.
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